Description
CH 275 is a peptide analog of somatostatin and binds preferably to somatostatin receptor 1 (sst1) with a Ki of 52 nM[1]. CH 275 acts as a potent and selective sst1 agonist (IC50=30.9 nM) and also displays IC50 values of 345 nM, >1 μM, >10 μM, >10 μM for human sst3, sst4, sst2 and sst5, respectively[2]. CH 275 can be used for the research of alzheimer’s disease[3].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)–Neuroscience-Neurodegeneration–C74H96N14O15S2—-[1]J E Rivier, et al. Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1). J Med Chem. 2001 Jun 21;44(13):2238-46.|[2]L Chen, et al. Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin. Biochem Biophys Res Commun. 1999 May 19;258(3):689-94.|[3]Per Nilsson, et al. Somatostatin receptor subtypes 1 and 4 redundantly regulate neprilysin, the major amyloid β-degrading enzyme, in brain.–174688-78-9–1485.77–99.71–O=C(N[C@H](C(N[C@@](C(N[C@H](C(N[C@@](C(N[C@H](C(N1)=O)CO)=O)([H])[C@H](O)C)=O)CC2=CC=CC=C2)=O)([H])[C@H](O)C)=O)CC(C=C3)=CC=C3CNC(C)C)[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CSSC[C@H]1C(O)=O)N)=O)CCCCN)=O)CC4=CC=CC=C4)=O)CC5=CC=CC=C5)=O)CC6=CNC7=CC=CC=C67–Neurological Disease–DMSO : 100 mg/mL (ultrasonic)|H2O : 50 mg/mL (ultrasonic)–Somatostatin Receptor–SSTR1–GPCR/G Protein;Neuronal Signaling–Peptides
